Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for TERN

Stock Name	Tern Plc
Ticker	TERN(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB00BFPMV798
LEI	2138005F87SODHL9CQ36

Show aggregate TERN holdings

News associated with TERN

Insider Buying: Tern Plc (LON:TERN) Insider Acquires 110,000 Shares of Stock: Tern Plc (LON:TERN – Get Free Report) insider Iain Ross acquired 110,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was acquired at an average cost of GBX 2 ($0.03) per share, for a total transaction of £2,200 ($2,982.24). Tern Price Performance Shares of LON TERN opened at […] - 2025-06-12 02:24:49
Millennium Management LLC Decreases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Millennium Management LLC lessened its stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 1.1% in the fourth quarter, HoldingsChannel reports. The fund owned 1,610,215 shares of the company’s stock after selling 18,319 shares during the period. Millennium Management LLC’s holdings in Terns Pharmaceuticals were worth $8,921,000 at the end of the most recent […] - 2025-05-26 04:38:51
Dimensional Fund Advisors LP Boosts Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Dimensional Fund Advisors LP raised its holdings in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 107.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,302,932 shares of the company’s stock after buying an additional 673,570 shares during the […] - 2025-05-12 04:47:01
Barclays PLC Purchases 575,069 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Barclays PLC grew its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 444.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 704,371 shares of the company’s stock after purchasing an additional 575,069 shares during the quarter. Barclays PLC owned approximately 0.83% […] - 2025-04-28 04:59:03
Renaissance Technologies LLC Grows Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Renaissance Technologies LLC increased its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 30.0% in the 4th quarter, Holdings Channel reports. The firm owned 623,134 shares of the company’s stock after purchasing an additional 143,634 shares during the period. Renaissance Technologies LLC’s holdings in Terns Pharmaceuticals were worth $3,452,000 at the […] - 2025-04-23 04:37:03
Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities: Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They currently have a $20.00 price objective on the stock. Separately, William Blair reissued a “market perform” rating on shares of Terns Pharmaceuticals in a research report on […] - 2025-04-23 02:10:57
Russell Investments Group Ltd. Trims Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Russell Investments Group Ltd. lessened its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 15.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 628,395 shares of the company’s stock after selling 116,292 shares during the quarter. Russell Investments Group Ltd.’s […] - 2025-04-17 06:35:15
ExodusPoint Capital Management LP Lowers Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): ExodusPoint Capital Management LP lowered its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 99.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,816 shares of the company’s stock after selling 1,637,315 shares during […] - 2025-04-15 04:39:12
Norges Bank Purchases New Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Norges Bank bought a new position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 849,389 shares of the company’s stock, valued at approximately $4,706,000. Several other hedge funds and other institutional investors also recently added to or reduced […] - 2025-04-10 05:02:57
Tern (LON:TERN) Share Price Passes Below 200 Day Moving Average – What’s Next?: Tern Plc (LON:TERN – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.40 ($0.02) and traded as low as GBX 1.15 ($0.01). Tern shares last traded at GBX 1.19 ($0.02), with a volume of 1,116,397 shares trading hands. Tern […] - 2025-03-28 05:58:57
Y Intercept Hong Kong Ltd Increases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Y Intercept Hong Kong Ltd increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 84.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 67,002 shares of the company’s stock after acquiring an additional 30,610 shares during the period. […] - 2025-03-04 06:58:50
Tern (LON:TERN) Stock Price Passes Below 200-Day Moving Average – Should You Sell?: Shares of Tern Plc (LON:TERN – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1.47 ($0.02) and traded as low as GBX 1.10 ($0.01). Tern shares last traded at GBX 1.17 ($0.01), with a volume of […] - 2025-03-04 06:24:48
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Consensus Price Target from Brokerages: Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among […] - 2025-03-03 04:18:50
Bleakley Financial Group LLC Increases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN): Bleakley Financial Group LLC increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 262.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,296 shares of the company’s stock after acquiring an additional 34,984 shares during the period. Bleakley […] - 2025-02-12 06:58:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TERN holdings

Date	Number of TERN Shares Held	Base Market Value of TERN Shares	Local Market Value of TERN Shares	Change in TERN Shares Held	Change in TERN Base Value	Current Price per TERN Share Held	Previous Price per TERN Share Held
2025-11-12 (Wednesday)	56,397	USD 1,144,859	USD 1,144,859	145	USD -12,807	USD 20.3	USD 20.58
2025-11-11 (Tuesday)	56,252	USD 1,157,666	USD 1,157,666	0	USD 82,128	USD 20.58	USD 19.12
2025-11-10 (Monday)	56,252	USD 1,075,538	USD 1,075,538	144	USD 39,223	USD 19.12	USD 18.47
2025-11-07 (Friday)	56,108	USD 1,036,315	USD 1,036,315	0	USD 12,344	USD 18.47	USD 18.25
2025-11-06 (Thursday)	56,108	USD 1,023,971	USD 1,023,971	144	USD 5,986	USD 18.25	USD 18.19
2025-11-05 (Wednesday)	55,964	USD 1,017,985	USD 1,017,985	145	USD 45,060	USD 18.19	USD 17.43
2025-11-04 (Tuesday)	55,819	USD 972,925	USD 972,925	0	USD 189,784	USD 17.43	USD 14.03
2025-11-03 (Monday)	55,819	USD 783,141	USD 783,141	0	USD 322,076	USD 14.03	USD 8.26
2025-10-31 (Friday)	55,819	USD 461,065	USD 461,065	0	USD 5,582	USD 8.26	USD 8.16
2025-10-30 (Thursday)	55,819	USD 455,483	USD 455,483	730	USD 13,669	USD 8.16	USD 8.02
2025-10-29 (Wednesday)	55,089	USD 441,814	USD 441,814	292	USD -28,892	USD 8.02	USD 8.59
2025-10-28 (Tuesday)	54,797	USD 470,706	USD 470,706	0	USD 29,042	USD 8.59	USD 8.06
2025-10-27 (Monday)	54,797	USD 441,664	USD 441,664	0	USD 15,891	USD 8.06	USD 7.77001

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TERN by Blackrock for IE00BDZVHG35

Show aggregate share trades of TERN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 145 20.300* 5.21
2025-11-10 BUY 144 19.120* 5.05
2025-11-06 BUY 144 18.250* 4.90
2025-11-05 BUY 145 18.600 16.830 17.007 GBX 2,466 4.83
2025-10-30 BUY 730 8.575 7.869 7.940 GBX 5,796 4.67
2025-10-29 BUY 292 8.020 8.580 8.524 GBX 2,489 4.65
2025-10-22 SELL -580 8.140 8.235 8.225 GBX -4,771 4.56 Loss of -2,128 on sale
2025-10-20 BUY 290 8.620 8.740 8.728 GBX 2,531 4.51
2025-10-17 BUY 724 8.410 8.740 8.707 GBX 6,304 4.49
2025-10-15 BUY 1,152 8.500 8.620 8.608 GBX 9,916 4.46
2025-10-03 BUY 1,029 8.230 8.320 8.311 GBX 8,552 4.42
2025-10-02 BUY 147 8.030 8.050 8.048 GBX 1,183 4.40
2025-09-30 BUY 294 7.510 7.900 7.861 GBX 2,311 4.36
2025-09-26 BUY 294 7.640 7.805 7.788 GBX 2,290 4.32
2025-09-25 BUY 294 7.440 7.810 7.773 GBX 2,285 4.30
2025-09-18 BUY 163 8.180 8.220 8.216 GBX 1,339 4.27
2025-09-17 BUY 492 7.400 7.750 7.715 GBX 3,796 4.25
2025-07-17 SELL -322 5.600 5.630 5.627 GBX -1,812 4.21 Loss of -457 on sale
2025-07-11 SELL -1,304 4.900 4.960 4.954 GBX -6,460 4.18 Loss of -1,003 on sale
2025-07-02 BUY 9,020 4.260 4.390 4.377 GBX 39,481 4.17
2025-06-25 BUY 326 4.060 4.080 4.078 GBX 1,329 4.18
2025-06-20 BUY 6,786 3.900 4.090 4.071 GBX 27,626 4.19
2025-06-11 BUY 282 4.100 4.230 4.217 GBX 1,189 4.20
2025-06-10 BUY 282 4.060 4.340 4.312 GBX 1,216 4.20
2025-06-04 SELL -141 3.510 3.580 3.573 GBX -504 4.22 Profit of 91 on sale
2025-04-23 BUY 141 2.880 3.060 3.042 GBX 429 4.57
2025-04-10 SELL -1,128 2.140 2.410 2.383 GBX -2,688 4.79 Profit of 2,716 on sale
2025-04-08 SELL -141 2.050 2.300 2.275 GBX -321 4.85 Profit of 363 on sale
2025-04-07 SELL -141 2.000 2.090 2.081 GBX -293 4.88 Profit of 395 on sale
2025-04-04 SELL -705 2.100 2.290 2.271 GBX -1,601 4.92 Profit of 1,865 on sale
2025-04-01 BUY 564 2.560 2.785 2.763 GBX 1,558 4.97
2025-03-31 SELL -423 2.760 2.880 2.868 GBX -1,213 5.00 Profit of 902 on sale
2025-03-14 SELL -2,256 3.180 3.500 3.468 GBX -7,824 5.28 Profit of 4,088 on sale
2025-03-07 SELL -282 3.490 3.670 3.652 GBX -1,030 5.42 Profit of 497 on sale
2025-03-04 SELL -141 3.510 3.540 3.537 GBX -499 5.50 Profit of 277 on sale
2025-02-25 BUY 282 3.710 3.980 3.953 GBX 1,115 5.66
2025-02-19 SELL -141 4.190 4.230 4.226 GBX -596 5.78 Profit of 220 on sale
2025-02-13 BUY 423 4.080 4.360 4.332 GBX 1,832 5.92
2025-02-12 BUY 141 4.340 4.350 4.349 GBX 613 5.95
2025-02-11 BUY 564 4.300 4.440 4.426 GBX 2,496 5.99
2025-01-02 BUY 4,325 5.670 5.765 5.755 GBX 24,893 6.56
2024-12-30 SELL -635 5.530 5.750 5.728 GBX -3,637 6.60 Profit of 551 on sale
2024-11-18 SELL -1,860 5.700 6.210 6.159 GBX -11,456 7.02 Profit of 1,596 on sale
2024-11-08 SELL -124 7.300 7.465 7.449 GBX -924 6.99 Loss of -57 on sale
2024-10-21 SELL -126 7.240 7.470 7.447 GBX -938 0.00 Loss of -938 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	145			20.300*		5.21
2025-11-10	BUY	144			19.120*		5.05
2025-11-06	BUY	144			18.250*		4.90
2025-11-05	BUY	145	18.600	16.830	17.007	GBX 2,466	4.83
2025-10-30	BUY	730	8.575	7.869	7.940	GBX 5,796	4.67
2025-10-29	BUY	292	8.020	8.580	8.524	GBX 2,489	4.65
2025-10-22	SELL	-580	8.140	8.235	8.225	GBX -4,771	4.56 Loss of -2,128 on sale
2025-10-20	BUY	290	8.620	8.740	8.728	GBX 2,531	4.51
2025-10-17	BUY	724	8.410	8.740	8.707	GBX 6,304	4.49
2025-10-15	BUY	1,152	8.500	8.620	8.608	GBX 9,916	4.46
2025-10-03	BUY	1,029	8.230	8.320	8.311	GBX 8,552	4.42
2025-10-02	BUY	147	8.030	8.050	8.048	GBX 1,183	4.40
2025-09-30	BUY	294	7.510	7.900	7.861	GBX 2,311	4.36
2025-09-26	BUY	294	7.640	7.805	7.788	GBX 2,290	4.32
2025-09-25	BUY	294	7.440	7.810	7.773	GBX 2,285	4.30
2025-09-18	BUY	163	8.180	8.220	8.216	GBX 1,339	4.27
2025-09-17	BUY	492	7.400	7.750	7.715	GBX 3,796	4.25
2025-07-17	SELL	-322	5.600	5.630	5.627	GBX -1,812	4.21 Loss of -457 on sale
2025-07-11	SELL	-1,304	4.900	4.960	4.954	GBX -6,460	4.18 Loss of -1,003 on sale
2025-07-02	BUY	9,020	4.260	4.390	4.377	GBX 39,481	4.17
2025-06-25	BUY	326	4.060	4.080	4.078	GBX 1,329	4.18
2025-06-20	BUY	6,786	3.900	4.090	4.071	GBX 27,626	4.19
2025-06-11	BUY	282	4.100	4.230	4.217	GBX 1,189	4.20
2025-06-10	BUY	282	4.060	4.340	4.312	GBX 1,216	4.20
2025-06-04	SELL	-141	3.510	3.580	3.573	GBX -504	4.22 Profit of 91 on sale
2025-04-23	BUY	141	2.880	3.060	3.042	GBX 429	4.57
2025-04-10	SELL	-1,128	2.140	2.410	2.383	GBX -2,688	4.79 Profit of 2,716 on sale
2025-04-08	SELL	-141	2.050	2.300	2.275	GBX -321	4.85 Profit of 363 on sale
2025-04-07	SELL	-141	2.000	2.090	2.081	GBX -293	4.88 Profit of 395 on sale
2025-04-04	SELL	-705	2.100	2.290	2.271	GBX -1,601	4.92 Profit of 1,865 on sale
2025-04-01	BUY	564	2.560	2.785	2.763	GBX 1,558	4.97
2025-03-31	SELL	-423	2.760	2.880	2.868	GBX -1,213	5.00 Profit of 902 on sale
2025-03-14	SELL	-2,256	3.180	3.500	3.468	GBX -7,824	5.28 Profit of 4,088 on sale
2025-03-07	SELL	-282	3.490	3.670	3.652	GBX -1,030	5.42 Profit of 497 on sale
2025-03-04	SELL	-141	3.510	3.540	3.537	GBX -499	5.50 Profit of 277 on sale
2025-02-25	BUY	282	3.710	3.980	3.953	GBX 1,115	5.66
2025-02-19	SELL	-141	4.190	4.230	4.226	GBX -596	5.78 Profit of 220 on sale
2025-02-13	BUY	423	4.080	4.360	4.332	GBX 1,832	5.92
2025-02-12	BUY	141	4.340	4.350	4.349	GBX 613	5.95
2025-02-11	BUY	564	4.300	4.440	4.426	GBX 2,496	5.99
2025-01-02	BUY	4,325	5.670	5.765	5.755	GBX 24,893	6.56
2024-12-30	SELL	-635	5.530	5.750	5.728	GBX -3,637	6.60 Profit of 551 on sale
2024-11-18	SELL	-1,860	5.700	6.210	6.159	GBX -11,456	7.02 Profit of 1,596 on sale
2024-11-08	SELL	-124	7.300	7.465	7.449	GBX -924	6.99 Loss of -57 on sale
2024-10-21	SELL	-126	7.240	7.470	7.447	GBX -938	0.00 Loss of -938 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TERN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	205,448	0	262,707	78.2%
2025-09-18	226,910	500	324,759	69.9%
2025-09-17	199,176	0	271,831	73.3%
2025-09-16	201,727	0	279,014	72.3%
2025-09-15	229,625	8,263	330,224	69.5%
2025-09-12	490,152	4,901	638,451	76.8%
2025-09-11	257,403	0	690,586	37.3%
2025-09-10	245,535	0	316,949	77.5%
2025-09-09	316,778	0	677,301	46.8%
2025-09-08	244,101	0	347,694	70.2%
2025-09-05	95,838	0	281,514	34.0%
2025-09-04	258,478	4	527,703	49.0%
2025-09-03	172,562	0	258,226	66.8%
2025-09-02	369,111	0	821,262	44.9%
2025-08-29	230,671	200	328,486	70.2%
2025-08-28	136,130	1,400	183,809	74.1%
2025-08-27	218,435	0	368,130	59.3%
2025-08-26	195,886	922	390,259	50.2%
2025-08-25	132,695	0	433,699	30.6%
2025-08-22	202,477	0	790,819	25.6%
2025-08-21	298,804	514	449,369	66.5%
2025-08-20	218,095	39	336,774	64.8%
2025-08-19	369,275	6,453	702,400	52.6%
2025-08-18	263,486	100	356,300	74.0%
2025-08-15	293,691	0	896,910	32.7%
2025-08-14	166,323	0	647,945	25.7%
2025-08-13	253,799	0	496,682	51.1%
2025-08-12	350,116	0	629,914	55.6%
2025-08-11	379,419	0	490,499	77.4%
2025-08-08	250,353	32	399,675	62.6%
2025-08-07	378,698	0	558,459	67.8%
2025-08-06	400,755	0	626,347	64.0%
2025-08-05	152,410	0	444,494	34.3%
2025-08-04	197,214	276	585,082	33.7%
2025-08-01	226,970	0	569,948	39.8%
2025-07-31	226,582	0	294,080	77.0%
2025-07-30	257,003	14	352,613	72.9%
2025-07-29	230,223	2,600	396,882	58.0%
2025-07-28	282,366	10	375,069	75.3%
2025-07-25	133,419	243	342,846	38.9%
2025-07-24	242,516	282	383,482	63.2%
2025-07-23	203,747	0	342,030	59.6%
2025-07-22	192,280	81	455,080	42.3%
2025-07-21	261,004	300	531,201	49.1%
2025-07-18	329,518	0	565,007	58.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE